nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Pharyngitis—Paclitaxel—ovarian cancer	0.00234	0.00234	CcSEcCtD
Solifenacin—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00233	0.00233	CcSEcCtD
Solifenacin—Oedema peripheral—Paclitaxel—ovarian cancer	0.00232	0.00232	CcSEcCtD
Solifenacin—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00231	0.00231	CcSEcCtD
Solifenacin—Pruritus—Chlorambucil—ovarian cancer	0.00231	0.00231	CcSEcCtD
Solifenacin—Urticaria—Topotecan—ovarian cancer	0.00231	0.00231	CcSEcCtD
Solifenacin—Urethral disorder—Paclitaxel—ovarian cancer	0.00231	0.00231	CcSEcCtD
Solifenacin—Abdominal pain—Topotecan—ovarian cancer	0.0023	0.0023	CcSEcCtD
Solifenacin—Dry eye—Doxorubicin—ovarian cancer	0.00229	0.00229	CcSEcCtD
Solifenacin—Urticaria—Melphalan—ovarian cancer	0.00226	0.00226	CcSEcCtD
Solifenacin—Bladder pain—Doxorubicin—ovarian cancer	0.00224	0.00224	CcSEcCtD
Solifenacin—Erythema multiforme—Paclitaxel—ovarian cancer	0.00223	0.00223	CcSEcCtD
Solifenacin—Infestation NOS—Docetaxel—ovarian cancer	0.00222	0.00222	CcSEcCtD
Solifenacin—Infestation—Docetaxel—ovarian cancer	0.00222	0.00222	CcSEcCtD
Solifenacin—Eye disorder—Paclitaxel—ovarian cancer	0.0022	0.0022	CcSEcCtD
Solifenacin—Renal failure—Docetaxel—ovarian cancer	0.00219	0.00219	CcSEcCtD
Solifenacin—Cardiac disorder—Paclitaxel—ovarian cancer	0.00219	0.00219	CcSEcCtD
Solifenacin—Decreased appetite—Vinorelbine—ovarian cancer	0.00216	0.00216	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00215	0.00215	CcSEcCtD
Solifenacin—Fatigue—Vinorelbine—ovarian cancer	0.00214	0.00214	CcSEcCtD
Solifenacin—Hypersensitivity—Topotecan—ovarian cancer	0.00214	0.00214	CcSEcCtD
Solifenacin—Angiopathy—Paclitaxel—ovarian cancer	0.00214	0.00214	CcSEcCtD
Solifenacin—Constipation—Vinorelbine—ovarian cancer	0.00213	0.00213	CcSEcCtD
Solifenacin—Immune system disorder—Paclitaxel—ovarian cancer	0.00213	0.00213	CcSEcCtD
Solifenacin—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00212	0.00212	CcSEcCtD
Solifenacin—Hepatobiliary disease—Docetaxel—ovarian cancer	0.0021	0.0021	CcSEcCtD
Solifenacin—Hypersensitivity—Melphalan—ovarian cancer	0.0021	0.0021	CcSEcCtD
Solifenacin—Asthenia—Topotecan—ovarian cancer	0.00209	0.00209	CcSEcCtD
Solifenacin—Vomiting—Chlorambucil—ovarian cancer	0.00208	0.00208	CcSEcCtD
Solifenacin—Mental disorder—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00206	0.00206	CcSEcCtD
Solifenacin—Pruritus—Topotecan—ovarian cancer	0.00206	0.00206	CcSEcCtD
Solifenacin—Malnutrition—Paclitaxel—ovarian cancer	0.00205	0.00205	CcSEcCtD
Solifenacin—Feeling abnormal—Vinorelbine—ovarian cancer	0.00205	0.00205	CcSEcCtD
Solifenacin—Renal impairment—Epirubicin—ovarian cancer	0.00204	0.00204	CcSEcCtD
Solifenacin—Asthenia—Melphalan—ovarian cancer	0.00204	0.00204	CcSEcCtD
Solifenacin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00203	0.00203	CcSEcCtD
Solifenacin—Pruritus—Melphalan—ovarian cancer	0.00201	0.00201	CcSEcCtD
Solifenacin—Dysgeusia—Paclitaxel—ovarian cancer	0.00201	0.00201	CcSEcCtD
Solifenacin—Pharyngitis—Docetaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Solifenacin—Urticaria—Vinorelbine—ovarian cancer	0.00198	0.00198	CcSEcCtD
Solifenacin—Urinary tract disorder—Docetaxel—ovarian cancer	0.00197	0.00197	CcSEcCtD
Solifenacin—Abdominal pain—Vinorelbine—ovarian cancer	0.00197	0.00197	CcSEcCtD
Solifenacin—Oedema peripheral—Docetaxel—ovarian cancer	0.00197	0.00197	CcSEcCtD
Solifenacin—Connective tissue disorder—Docetaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Solifenacin—Urethral disorder—Docetaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Solifenacin—Nausea—Chlorambucil—ovarian cancer	0.00194	0.00194	CcSEcCtD
Solifenacin—Vision blurred—Paclitaxel—ovarian cancer	0.00193	0.00193	CcSEcCtD
Solifenacin—Dizziness—Topotecan—ovarian cancer	0.00192	0.00192	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00191	0.00191	CcSEcCtD
Solifenacin—Renal impairment—Doxorubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Solifenacin—Erythema multiforme—Docetaxel—ovarian cancer	0.00189	0.00189	CcSEcCtD
Solifenacin—Angioedema—Paclitaxel—ovarian cancer	0.00187	0.00187	CcSEcCtD
Solifenacin—Eye disorder—Docetaxel—ovarian cancer	0.00187	0.00187	CcSEcCtD
Solifenacin—Cardiac disorder—Docetaxel—ovarian cancer	0.00185	0.00185	CcSEcCtD
Solifenacin—Vomiting—Topotecan—ovarian cancer	0.00185	0.00185	CcSEcCtD
Solifenacin—Rash—Topotecan—ovarian cancer	0.00183	0.00183	CcSEcCtD
Solifenacin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00183	0.00183	CcSEcCtD
Solifenacin—Dermatitis—Topotecan—ovarian cancer	0.00183	0.00183	CcSEcCtD
Solifenacin—Headache—Topotecan—ovarian cancer	0.00182	0.00182	CcSEcCtD
Solifenacin—Palpitations—Paclitaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Solifenacin—Angiopathy—Docetaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Solifenacin—Vomiting—Melphalan—ovarian cancer	0.00181	0.00181	CcSEcCtD
Solifenacin—Immune system disorder—Docetaxel—ovarian cancer	0.0018	0.0018	CcSEcCtD
Solifenacin—Mediastinal disorder—Docetaxel—ovarian cancer	0.0018	0.0018	CcSEcCtD
Solifenacin—Liver function test abnormal—Epirubicin—ovarian cancer	0.0018	0.0018	CcSEcCtD
Solifenacin—Rash—Melphalan—ovarian cancer	0.0018	0.0018	CcSEcCtD
Solifenacin—Dermatitis—Melphalan—ovarian cancer	0.00179	0.00179	CcSEcCtD
Solifenacin—Cough—Paclitaxel—ovarian cancer	0.00179	0.00179	CcSEcCtD
Solifenacin—Asthenia—Vinorelbine—ovarian cancer	0.00178	0.00178	CcSEcCtD
Solifenacin—Dry skin—Epirubicin—ovarian cancer	0.00178	0.00178	CcSEcCtD
Solifenacin—Abdominal pain upper—Epirubicin—ovarian cancer	0.00178	0.00178	CcSEcCtD
Solifenacin—Hypertension—Paclitaxel—ovarian cancer	0.00177	0.00177	CcSEcCtD
Solifenacin—Pruritus—Vinorelbine—ovarian cancer	0.00176	0.00176	CcSEcCtD
Solifenacin—Mental disorder—Docetaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Solifenacin—Malnutrition—Docetaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00173	0.00173	CcSEcCtD
Solifenacin—Nausea—Topotecan—ovarian cancer	0.00173	0.00173	CcSEcCtD
Solifenacin—Muscular weakness—Epirubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Solifenacin—Dry mouth—Paclitaxel—ovarian cancer	0.00171	0.00171	CcSEcCtD
Solifenacin—Dysgeusia—Docetaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Solifenacin—Nausea—Melphalan—ovarian cancer	0.00169	0.00169	CcSEcCtD
Solifenacin—Confusional state—Paclitaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Solifenacin—Influenza—Epirubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Solifenacin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00167	0.00167	CcSEcCtD
Solifenacin—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Solifenacin—Infection—Paclitaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Solifenacin—Dry skin—Doxorubicin—ovarian cancer	0.00165	0.00165	CcSEcCtD
Solifenacin—Dizziness—Vinorelbine—ovarian cancer	0.00164	0.00164	CcSEcCtD
Solifenacin—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Solifenacin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Solifenacin—Tachycardia—Paclitaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Solifenacin—Skin disorder—Paclitaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Solifenacin—Muscular weakness—Doxorubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Solifenacin—Vomiting—Vinorelbine—ovarian cancer	0.00158	0.00158	CcSEcCtD
Solifenacin—Dysuria—Epirubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Solifenacin—Rash—Vinorelbine—ovarian cancer	0.00157	0.00157	CcSEcCtD
Solifenacin—Dermatitis—Vinorelbine—ovarian cancer	0.00157	0.00157	CcSEcCtD
Solifenacin—Headache—Vinorelbine—ovarian cancer	0.00156	0.00156	CcSEcCtD
Solifenacin—Influenza—Doxorubicin—ovarian cancer	0.00156	0.00156	CcSEcCtD
Solifenacin—Palpitations—Docetaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Solifenacin—Cough—Docetaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Solifenacin—Hypertension—Docetaxel—ovarian cancer	0.0015	0.0015	CcSEcCtD
Solifenacin—Infestation NOS—Epirubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
Solifenacin—Infestation—Epirubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
Solifenacin—Somnolence—Paclitaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Solifenacin—Nausea—Vinorelbine—ovarian cancer	0.00148	0.00148	CcSEcCtD
Solifenacin—Renal failure—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Solifenacin—Dyspepsia—Paclitaxel—ovarian cancer	0.00147	0.00147	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00147	0.00147	CcSEcCtD
Solifenacin—Urinary tract infection—Epirubicin—ovarian cancer	0.00146	0.00146	CcSEcCtD
Solifenacin—Dysuria—Doxorubicin—ovarian cancer	0.00146	0.00146	CcSEcCtD
Solifenacin—Decreased appetite—Paclitaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Solifenacin—Dry mouth—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Solifenacin—Fatigue—Paclitaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Solifenacin—Constipation—Paclitaxel—ovarian cancer	0.00143	0.00143	CcSEcCtD
Solifenacin—Confusional state—Docetaxel—ovarian cancer	0.00143	0.00143	CcSEcCtD
Solifenacin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Solifenacin—Anaphylactic shock—Docetaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Solifenacin—Infection—Docetaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Solifenacin—Nervous system disorder—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Solifenacin—Infestation—Doxorubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Solifenacin—Infestation NOS—Doxorubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Solifenacin—Tachycardia—Docetaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Solifenacin—Feeling abnormal—Paclitaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Solifenacin—Skin disorder—Docetaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Solifenacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Solifenacin—Renal failure—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Solifenacin—Urinary tract infection—Doxorubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Solifenacin—Pharyngitis—Epirubicin—ovarian cancer	0.00134	0.00134	CcSEcCtD
Solifenacin—Urinary tract disorder—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Solifenacin—Urticaria—Paclitaxel—ovarian cancer	0.00133	0.00133	CcSEcCtD
Solifenacin—Oedema peripheral—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Solifenacin—Connective tissue disorder—Epirubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Solifenacin—Abdominal pain—Paclitaxel—ovarian cancer	0.00132	0.00132	CcSEcCtD
Solifenacin—Urethral disorder—Epirubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Solifenacin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Solifenacin—Erythema multiforme—Epirubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Solifenacin—Somnolence—Docetaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Solifenacin—Eye disorder—Epirubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Solifenacin—Cardiac disorder—Epirubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Solifenacin—Dyspepsia—Docetaxel—ovarian cancer	0.00125	0.00125	CcSEcCtD
Solifenacin—Pharyngitis—Doxorubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Solifenacin—Decreased appetite—Docetaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Solifenacin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Solifenacin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Solifenacin—Oedema peripheral—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Solifenacin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Solifenacin—Fatigue—Docetaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Solifenacin—Angiopathy—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Solifenacin—Urethral disorder—Doxorubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Solifenacin—Immune system disorder—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Solifenacin—Mediastinal disorder—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Solifenacin—Constipation—Docetaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Solifenacin—Asthenia—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Solifenacin—Pruritus—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Solifenacin—Mental disorder—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Solifenacin—Erythema multiforme—Doxorubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Solifenacin—Malnutrition—Epirubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Solifenacin—Feeling abnormal—Docetaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Solifenacin—Eye disorder—Doxorubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Solifenacin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Solifenacin—Cardiac disorder—Doxorubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Solifenacin—Dysgeusia—Epirubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Solifenacin—Angiopathy—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Solifenacin—Immune system disorder—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Solifenacin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Solifenacin—Abdominal pain—Docetaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Solifenacin—Dizziness—Paclitaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Solifenacin—Vision blurred—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Solifenacin—Mental disorder—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Solifenacin—Malnutrition—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Solifenacin—Vomiting—Paclitaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Solifenacin—Dysgeusia—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Solifenacin—Rash—Paclitaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Solifenacin—Dermatitis—Paclitaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Solifenacin—Headache—Paclitaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Solifenacin—Hypersensitivity—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Solifenacin—Palpitations—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Solifenacin—Cough—Epirubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Solifenacin—Vision blurred—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Solifenacin—Asthenia—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Solifenacin—Hypertension—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Solifenacin—Pruritus—Docetaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Solifenacin—Nausea—Paclitaxel—ovarian cancer	0.000994	0.000994	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000991	0.000991	CcSEcCtD
Solifenacin—Dry mouth—Epirubicin—ovarian cancer	0.000976	0.000976	CcSEcCtD
Solifenacin—Confusional state—Epirubicin—ovarian cancer	0.000964	0.000964	CcSEcCtD
Solifenacin—Palpitations—Doxorubicin—ovarian cancer	0.000958	0.000958	CcSEcCtD
Solifenacin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000956	0.000956	CcSEcCtD
Solifenacin—Infection—Epirubicin—ovarian cancer	0.00095	0.00095	CcSEcCtD
Solifenacin—Cough—Doxorubicin—ovarian cancer	0.000946	0.000946	CcSEcCtD
Solifenacin—Nervous system disorder—Epirubicin—ovarian cancer	0.000938	0.000938	CcSEcCtD
Solifenacin—Dizziness—Docetaxel—ovarian cancer	0.000938	0.000938	CcSEcCtD
Solifenacin—Hypertension—Doxorubicin—ovarian cancer	0.000936	0.000936	CcSEcCtD
Solifenacin—Tachycardia—Epirubicin—ovarian cancer	0.000934	0.000934	CcSEcCtD
Solifenacin—Skin disorder—Epirubicin—ovarian cancer	0.000929	0.000929	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000917	0.000917	CcSEcCtD
Solifenacin—Dry mouth—Doxorubicin—ovarian cancer	0.000903	0.000903	CcSEcCtD
Solifenacin—Vomiting—Docetaxel—ovarian cancer	0.000902	0.000902	CcSEcCtD
Solifenacin—Rash—Docetaxel—ovarian cancer	0.000894	0.000894	CcSEcCtD
Solifenacin—Dermatitis—Docetaxel—ovarian cancer	0.000893	0.000893	CcSEcCtD
Solifenacin—Confusional state—Doxorubicin—ovarian cancer	0.000892	0.000892	CcSEcCtD
Solifenacin—Headache—Docetaxel—ovarian cancer	0.000888	0.000888	CcSEcCtD
Solifenacin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000885	0.000885	CcSEcCtD
Solifenacin—Infection—Doxorubicin—ovarian cancer	0.000879	0.000879	CcSEcCtD
Solifenacin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000868	0.000868	CcSEcCtD
Solifenacin—Tachycardia—Doxorubicin—ovarian cancer	0.000864	0.000864	CcSEcCtD
Solifenacin—Skin disorder—Doxorubicin—ovarian cancer	0.00086	0.00086	CcSEcCtD
Solifenacin—Somnolence—Epirubicin—ovarian cancer	0.00085	0.00085	CcSEcCtD
Solifenacin—Nausea—Docetaxel—ovarian cancer	0.000842	0.000842	CcSEcCtD
Solifenacin—Dyspepsia—Epirubicin—ovarian cancer	0.000842	0.000842	CcSEcCtD
Solifenacin—Decreased appetite—Epirubicin—ovarian cancer	0.000831	0.000831	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000826	0.000826	CcSEcCtD
Solifenacin—Fatigue—Epirubicin—ovarian cancer	0.000825	0.000825	CcSEcCtD
Solifenacin—Constipation—Epirubicin—ovarian cancer	0.000818	0.000818	CcSEcCtD
Solifenacin—Feeling abnormal—Epirubicin—ovarian cancer	0.000788	0.000788	CcSEcCtD
Solifenacin—Somnolence—Doxorubicin—ovarian cancer	0.000787	0.000787	CcSEcCtD
Solifenacin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000782	0.000782	CcSEcCtD
Solifenacin—Dyspepsia—Doxorubicin—ovarian cancer	0.000779	0.000779	CcSEcCtD
Solifenacin—Decreased appetite—Doxorubicin—ovarian cancer	0.000769	0.000769	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000764	0.000764	CcSEcCtD
Solifenacin—Fatigue—Doxorubicin—ovarian cancer	0.000763	0.000763	CcSEcCtD
Solifenacin—Urticaria—Epirubicin—ovarian cancer	0.00076	0.00076	CcSEcCtD
Solifenacin—Constipation—Doxorubicin—ovarian cancer	0.000757	0.000757	CcSEcCtD
Solifenacin—Abdominal pain—Epirubicin—ovarian cancer	0.000756	0.000756	CcSEcCtD
Solifenacin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000729	0.000729	CcSEcCtD
Solifenacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000724	0.000724	CcSEcCtD
Solifenacin—Hypersensitivity—Epirubicin—ovarian cancer	0.000705	0.000705	CcSEcCtD
Solifenacin—Urticaria—Doxorubicin—ovarian cancer	0.000703	0.000703	CcSEcCtD
Solifenacin—Abdominal pain—Doxorubicin—ovarian cancer	0.0007	0.0007	CcSEcCtD
Solifenacin—Asthenia—Epirubicin—ovarian cancer	0.000686	0.000686	CcSEcCtD
Solifenacin—Pruritus—Epirubicin—ovarian cancer	0.000677	0.000677	CcSEcCtD
Solifenacin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000652	0.000652	CcSEcCtD
Solifenacin—Asthenia—Doxorubicin—ovarian cancer	0.000635	0.000635	CcSEcCtD
Solifenacin—Dizziness—Epirubicin—ovarian cancer	0.000633	0.000633	CcSEcCtD
Solifenacin—Pruritus—Doxorubicin—ovarian cancer	0.000626	0.000626	CcSEcCtD
Solifenacin—Vomiting—Epirubicin—ovarian cancer	0.000608	0.000608	CcSEcCtD
Solifenacin—Rash—Epirubicin—ovarian cancer	0.000603	0.000603	CcSEcCtD
Solifenacin—Dermatitis—Epirubicin—ovarian cancer	0.000603	0.000603	CcSEcCtD
Solifenacin—Headache—Epirubicin—ovarian cancer	0.000599	0.000599	CcSEcCtD
Solifenacin—Dizziness—Doxorubicin—ovarian cancer	0.000585	0.000585	CcSEcCtD
Solifenacin—Nausea—Epirubicin—ovarian cancer	0.000568	0.000568	CcSEcCtD
Solifenacin—Vomiting—Doxorubicin—ovarian cancer	0.000563	0.000563	CcSEcCtD
Solifenacin—Rash—Doxorubicin—ovarian cancer	0.000558	0.000558	CcSEcCtD
Solifenacin—Dermatitis—Doxorubicin—ovarian cancer	0.000558	0.000558	CcSEcCtD
Solifenacin—Headache—Doxorubicin—ovarian cancer	0.000554	0.000554	CcSEcCtD
Solifenacin—Nausea—Doxorubicin—ovarian cancer	0.000526	0.000526	CcSEcCtD
